Home » Archives for July 20, 2021
July 20, 2021
RECENT POSTS
ADVERTISEMENT
WillScot Mobile Mini Holdings to Announce Second Quarter 2021 Results on August 5, 2021
PHOENIX, July 20, 2021 (GLOBE NEWSWIRE) — WillScot Mobile Mini Holdings Corporation (Nasdaq: WSC) today announced that it will release its second quarter 2021 financial results on Thursday, August 5, 2021 after the markets close. Chief Executive Officer, Brad Soultz and Chief Financial Officer, Tim Boswell will host a conference
Eyenuk Announces $6.2 Million Financing to Accelerate Adoption of FDA-cleared AI Technology for Detection of Diabetic Retinopathy
Financing led by AXA IM’s Impact Investing strategy LOS ANGELES, July 20, 2021 (GLOBE NEWSWIRE) — Eyenuk, Inc., a global artificial intelligence (AI) medical technology and services company and the leader in real-world applications for AI Eye Screening, today announced that it has completed a financing round of US$6.2 million
Blue California Commercializes Nicotinamide Mononucleotide (NMN) for Supporting an Increased Healthspan
A better cost-effective option is now available for dietary supplement, functional food, and beverage manufacturers. Rancho Santa Margarita, Calif., July 20, 2021 (GLOBE NEWSWIRE) — Blue California joins with the innovative Massachusetts-based biotech company Conagen to announce the commercialization of high-purity, fermentation-derived nicotinamide mononucleotide (NMN). A nature-based metabolic component which
Halfords Implements Descartes’ Last Mile Delivery Solution to Enable Dynamic Delivery Appointment Pricing in Mobile Service Business and as Part of New Avayler Field Service Software Platform
LONDON, July 20, 2021 (GLOBE NEWSWIRE) — Descartes Systems Group (Nasdaq:DSGX) (TSX:DSG), the global leader in uniting logistics-intensive businesses in commerce, has announced that UK-headquartered Halfords, a leading automotive products and services retailer, is using Descartes’ last mile delivery solution to enable dynamic delivery pricing in its customer-facing mobile tire
Junshi Biosciences and Immorna Announce Joint Venture to Develop Innovative Self-Replicating and Conventional mRNA Therapeutics and Vaccines
SHANGHAI, China, July 20, 2021 (GLOBE NEWSWIRE) — Junshi Biosciences (HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies, announced today that the company has established a joint venture with Immorna, a fast-growing biotechnology company focusing on the process development